相关实验视频

Updated: Sep 11, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

罗皮尼罗尔通过多巴胺受体D2-独立机制发挥作用,以改善TARDBP突变iPSC衍生的运动神经元中肌缩性侧面硬化症表型

Hirotsugu Asano¹, Tetsuya Kawaguchi¹, Chris Kato²

¹Drug Discovery Research Department, K Pharma, Inc., Fujisawa-shi, Kanagawa, Japan.

Journal of neurochemistry

|August 19, 2025

概括

罗皮尼罗尔化 (ROPI) 在肌缩侧硬化症 (ALS) 中显示出独立于多巴胺受体D2 (DRD2) 的治疗作用. 这表明ROPI具有更广泛的治疗潜力,超出其已知的DRD2对ALS治疗的agonism.

科学领域:

神经科学是一个神经科学.
干细胞生物学干细胞生物学
药理学药理学是指药理学的学科.

背景情况:

肌缩侧面硬化症 (ALS) 是一种神经退行性疾病,导致运动神经元退化.
罗宾醇化物 (ROPI) 是一种DRD2激动剂,是通过iPSC衍生的运动神经元查确定的一种潜在的ALS治疗药物.
以前的试验表明ROPI的安全性和有效性,但其作用机制尚不清楚.

研究的目的:

调查ROPI在ALS的治疗效果是否依赖于多巴胺受体D2 (DRD2).
在ALS病理学中探索ROPI的潜在DRD2独立机制.

主要方法:

来自ALS患者的DRD2-缺陷诱导多能干细胞 (iPSCs) 产生.
评估了ROPI对神经元细胞死亡,反应性氧物种 (ROS) 和神经元过激活在DRD2-缺乏和控制iPSC衍生的运动神经元的影响.
分析了ROPI对RNA剪接和线粒体蛋白mRNA表达的影响.

主要成果:

ROPI 减少了神经元细胞死亡,ROS 生产和过度兴奋,这与DRD2.2无关.
ROPI纠正了异常的RNA拼接,并以DRD2-独立的方式恢复了线粒体蛋白mRNA表达.
这些发现表明,ROPI具有性,DRD2-独立的治疗效果.

结论:

在ALS中ROPI的治疗效益不仅仅是由DRD2激动作用介导的.
ROPI表现出显著的DRD2独立作用,包括RNA剪接和线粒体功能的调节.
罗皮提出了一种新的治疗策略,针对ALS病理学的多个途径.

关键词:

在TARDBP中,TARDBP是TARDBP.异常的RNA拼接.骨髓缩侧面硬化症 (ALS) 是一种多巴胺D2受体的受体神经元过度兴奋的发生.罗宾尼罗尔 (Ropinirole) 是一种制剂.

更多相关视频

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...